title: Management of chronic hepatitis B in patients from special populations.
abstract: Here we review the management of chronic hepatitis B (CHB) in four special categories of patients: CHB in pregnancy, in patients on immunosuppressive treatments, in patients undergoing liver transplantation, and in patients coinfected with human immunodeficiency virus (HIV) or hepatitis C virus (HCV).
authors.affiliation: Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong 999077, China.
authors.forename: Ching-Lung
authors.initials: CL
authors.lastname: Lai
authors.affiliation: Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong 999077, China.
authors.forename: Man-Fung
authors.initials: MF
authors.lastname: Yuen
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects; D000998:Antiviral Agents / Q000627:therapeutic use; D060085:Coinfection / Q000150:complications; D005260:Female; D015658:HIV Infections / Q000150:complications; D019694:Hepatitis B, Chronic / Q000628:therapy*; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000209:etiology / Q000517:prevention & control; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D016031:Liver Transplantation; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha